A detailed history of Dimensional Fund Advisors LP transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,730,480 shares of ALLO stock, worth $5.32 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,730,480
Previous 2,550,640 7.05%
Holding current value
$5.32 Million
Previous $5.94 Million 28.66%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$2.08 - $3.5 $374,067 - $629,440
179,840 Added 7.05%
2,730,480 $7.65 Million
Q2 2024

Aug 09, 2024

BUY
$2.23 - $4.38 $1.13 Million - $2.22 Million
507,021 Added 24.81%
2,550,640 $5.94 Million
Q1 2024

May 10, 2024

BUY
$2.92 - $5.63 $1.48 Million - $2.86 Million
508,374 Added 33.11%
2,043,619 $9.13 Million
Q4 2023

Feb 07, 2024

SELL
$2.28 - $3.5 $691,093 - $1.06 Million
-303,111 Reduced 16.49%
1,535,245 $4.93 Million
Q3 2023

Nov 09, 2023

BUY
$3.17 - $5.96 $1.73 Million - $3.26 Million
546,215 Added 42.27%
1,838,356 $5.83 Million
Q2 2023

Aug 09, 2023

SELL
$4.53 - $6.74 $3.43 Million - $5.1 Million
-757,115 Reduced 36.95%
1,292,141 $6.42 Million
Q1 2023

May 12, 2023

SELL
$4.92 - $8.21 $1.68 Million - $2.8 Million
-340,848 Reduced 14.26%
2,049,256 $10.1 Million
Q4 2022

Feb 09, 2023

BUY
$5.62 - $11.11 $3.68 Million - $7.28 Million
655,317 Added 37.78%
2,390,104 $15 Million
Q3 2022

Nov 10, 2022

BUY
$10.32 - $17.28 $4.95 Million - $8.3 Million
480,099 Added 38.26%
1,734,787 $18.7 Million
Q2 2022

Aug 12, 2022

BUY
$6.78 - $12.28 $3.04 Million - $5.51 Million
448,701 Added 55.67%
1,254,688 $14.3 Million
Q1 2022

May 13, 2022

BUY
$7.65 - $15.29 $468,631 - $936,650
61,259 Added 8.23%
805,987 $7.34 Million
Q4 2021

Feb 09, 2022

BUY
$13.13 - $24.52 $5.3 Million - $9.9 Million
403,573 Added 118.3%
744,728 $11.1 Million
Q3 2021

Nov 12, 2021

BUY
$21.01 - $27.64 $6.71 Million - $8.83 Million
319,311 Added 1461.78%
341,155 $8.77 Million
Q1 2021

May 14, 2021

SELL
$25.79 - $39.02 $606,297 - $917,321
-23,509 Reduced 51.84%
21,844 $771,000
Q4 2020

Feb 25, 2021

BUY
$25.24 - $43.45 $1.14 Million - $1.97 Million
45,353 New
45,353 $1.15 Million

Others Institutions Holding ALLO

About Allogene Therapeutics, Inc.


  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $280M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.